{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T15:12:46Z","timestamp":1793373166428,"version":"4.5.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Hematology"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1053\/j.seminhematol.2016.07.004","type":"journal-article","created":{"date-parts":[[2016,7,26]],"date-time":"2016-07-26T07:29:23Z","timestamp":1469518163000},"page":"257-266","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Haploidentical cord transplantation\u2014The best of both worlds"],"prefix":"10.1053","volume":"53","author":[{"given":"Koen","family":"van Besien","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Childs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.seminhematol.2016.07.004_bib1","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1111\/j.1365-2141.1999.01337.x","article-title":"A history of haemopoietic cell transplantation","volume":"105","author":"Thomas","year":"1999","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2016.07.004_bib2","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1056\/NEJM195709122571102","article-title":"Intravenous infusion of bone marrow in patients receiving radiation and chemotherapy","volume":"257","author":"Thomas","year":"1957","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminhematol.2016.07.004_bib3","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1056\/NEJM198910263211707","article-title":"Hematopoietic reconstitution in a patient with Fanconi\u05f3s anemia by means of umbilical-cord blood from an HLA-identical sibling","volume":"321","author":"Gluckman","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminhematol.2016.07.004_bib4","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/j.1365-2141.2011.08598.x","article-title":"Milestones in umbilical cord blood transplantation","volume":"154","author":"Gluckman","year":"2011","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2016.07.004_bib5","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S0301-472X(03)00067-5","article-title":"Unrelated umbilical cord blood transplants in adults: Early recovery of neutrophils by supportive co-transplantation of a low number of highly purified peripheral blood CD34+ cells from an HLA-haploidentical donor","volume":"31","author":"Fernandez","year":"2003","journal-title":"Exp Hematol"},{"key":"10.1053\/j.seminhematol.2016.07.004_bib6","doi-asserted-by":"crossref","first-page":"6438","DOI":"10.1182\/blood-2011-08-372508","article-title":"Reduced-intensity conditioning with combined haploidentical and cord blood transplantation results in rapid engraftment, low GVHD, and durable remissions","volume":"118","author":"Liu","year":"2011","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2016.07.004_bib7","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.bbmt.2012.11.001","article-title":"Umbilical cord blood transplantation supported by third-party donor cells: rationale, results, and applications","volume":"19","author":"van Besien","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1053\/j.seminhematol.2016.07.004_bib8","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1182\/blood-2010-04-280966","article-title":"How I treat: the selection and acquisition of unrelated cord blood grafts","volume":"117","author":"Barker","year":"2011","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2016.07.004_bib9","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1182\/blood-2013-05-506253","article-title":"Impact of allele-level HLA matching on outcomes after myeloablative single unit umbilical cord blood transplantation for hematologic malignancy","volume":"123","author":"Eapen","year":"2014","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2016.07.004_bib10","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/trf.12257","article-title":"Optimizing donor selection for public cord blood banking: influence of maternal, infant, and collection characteristics on cord blood unit quality","volume":"54","author":"Page","year":"2014","journal-title":"Transfusion"},{"key":"10.1053\/j.seminhematol.2016.07.004_bib11","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1111\/j.1537-2995.2005.04429.x","article-title":"Characterization of banked umbilical cord blood hematopoietic progenitor cells and lymphocyte subsets and correlation with ethnicity, birth weight, sex, and type of delivery: a Cord Blood Transplantation (COBLT) Study report","volume":"45","author":"Cairo","year":"2005","journal-title":"Transfusion"},{"issue":"5","key":"10.1053\/j.seminhematol.2016.07.004_bib12","doi-asserted-by":"crossref","first-page":"634","DOI":"10.3324\/haematol.2015.138594","article-title":"Reduced intensity haplo plus single cord transplant compared to double cord transplant: improved engraftment and survival free of progression and GVHD (GRFS)","volume":"101","author":"van Besien","year":"2016","journal-title":"Haematologica"},{"key":"10.1053\/j.seminhematol.2016.07.004_bib13","doi-asserted-by":"crossref","first-page":"5591","DOI":"10.1182\/blood-2011-12-400630","article-title":"Reduced-intensity conditioning transplantation in acute leukemia: the effect of source of unrelated donor stem cells on outcomes","volume":"119","author":"Brunstein","year":"2012","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2016.07.004_bib14","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1182\/blood-2011-03-344853","article-title":"Alternative donor transplantation after reduced intensity conditioning: results of parallel phase 2 trials using partially HLA-mismatched related bone marrow or unrelated double umbilical cord blood grafts","volume":"118","author":"Brunstein","year":"2011","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2016.07.004_bib15","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/j.bbmt.2014.02.020","article-title":"Alternative donor transplantation for older patients with acute myeloid leukemia in first complete remission: a Center for International Blood and Marrow Transplant Research-EUROCORD analysis","volume":"20","author":"Weisdorf","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"issue":"12","key":"10.1053\/j.seminhematol.2016.07.004_bib16","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1038\/bmt.2010.32","article-title":"Feasibility of clofarabine cytoreduction before allogeneic transplant conditioning for refractory AML","volume":"45","author":"Locke","year":"2010","journal-title":"Bone Marrow Transplant"},{"key":"10.1053\/j.seminhematol.2016.07.004_bib17","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1038\/bmt.2013.79","article-title":"A novel clofarabine bridge strategy facilitates allogeneic transplantation in patients with relapsed\/refractory leukemia and high-risk myelodysplastic syndromes","volume":"48","author":"Locke","year":"2013","journal-title":"Bone Marrow Transplant"},{"issue":"10","key":"10.1053\/j.seminhematol.2016.07.004_bib18","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1016\/j.bbmt.2015.06.001","article-title":"Sufficient immune-suppression with thymoglobulin is essential for a successful haplo-myeloid bridge in haplo-cord blood transplantation","volume":"21","author":"Lindemans","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1053\/j.seminhematol.2016.07.004_bib19","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.jcyt.2015.02.005","article-title":"Topping it up: methods to improve cord blood transplantation outcomes by increasing the number of CD34+ cells","volume":"17","author":"Lindemans","year":"2015","journal-title":"Cytotherapy"},{"key":"10.1053\/j.seminhematol.2016.07.004_bib20","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1182\/blood-2014-10-609032","article-title":"Composite end point of graft-versus-host disease-free, relapse-free survival after allogeneic hematopoietic cell transplantation","volume":"125","author":"Holtan","year":"2015","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2016.07.004_bib21","first-page":"288","article-title":"One-unit versus two-unit cord-blood transplantation","volume":"372","author":"Wagner","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminhematol.2016.07.004_bib22","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3389\/fimmu.2012.00093","article-title":"The use of donor-derived veto cells in hematopoietic stem cell transplantation","volume":"3","author":"Ophir","year":"2012","journal-title":"Front Immunol"},{"key":"10.1053\/j.seminhematol.2016.07.004_bib23","doi-asserted-by":"crossref","first-page":"3664","DOI":"10.1182\/blood-2014-01-552984","article-title":"Validation and refinement of the disease risk index for allogeneic stem cell transplantation","volume":"123","author":"Armand","year":"2014","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2016.07.004_bib24","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1016\/j.bbmt.2015.07.029","article-title":"High disease-free survival with enhanced protection against relapse after double-unit cord blood transplantation when compared with T cell-depleted unrelated donor transplantation in patients with acute leukemia and chronic myelogenous leukemia","volume":"21","author":"Ponce","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1053\/j.seminhematol.2016.07.004_bib25","doi-asserted-by":"crossref","first-page":"4293","DOI":"10.1182\/blood-2009-05-220525","article-title":"Relapse risk after umbilical cord blood transplantation: enhanced graft-versus-leukemia effect in recipients of 2 units","volume":"114","author":"Verneris","year":"2009","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2016.07.004_bib26","unstructured":"van Besien K, Koshy N, Gergis U, et al. Cord blood chimerism and relapse after haplo-cord transplantation. Leuk Lymphoma 2016 Jun 23:1-10. [Epub ahead of print]."},{"issue":"6","key":"10.1053\/j.seminhematol.2016.07.004_bib27","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/j.bbmt.2016.02.010","article-title":"Frequency and risk factors associated with cord graft failure (CGF) after transplant with single unit umbilical cord cells supplemented by haploidentical cells (Haplo-Cord) with reduced-intensity conditioning","volume":"22","author":"Tsai","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"issue":"Suppl 1","key":"10.1053\/j.seminhematol.2016.07.004_bib28","doi-asserted-by":"crossref","first-page":"4385","DOI":"10.1182\/blood.V126.23.4385.4385","article-title":"Predictors and GVL effects of UCB Chimerism after haplo-cord transplant","volume":"126","author":"Koshy","year":"2015","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2016.07.004_bib29","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.bbmt.2010.06.011","volume":"17","author":"Peffault de","year":"2011","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1053\/j.seminhematol.2016.07.004_bib30","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1182\/blood.V124.21.1235.1235","article-title":"Haplo-cord transplantation vs unrelated donor stem cell transplantation in patients with AML\/MDS older than 50","volume":"124","author":"Rhodes","year":"2014","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2016.07.004_bib31","first-page":"1","article-title":"Lower dose of antithymocyte globulin does not increase graft-versus-host disease in patients undergoing reduced-intensity conditioning allogeneic hematopoietic stem cell transplant","author":"Salem","year":"2014","journal-title":"Leuk.Lymphoma"},{"key":"10.1053\/j.seminhematol.2016.07.004_bib32","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1182\/blood-2013-05-502385","article-title":"Impact of thymoglobulin prior to pediatric unrelated umbilical cord blood transplantation on immune reconstitution and clinical outcome","volume":"123","author":"Lindemans","year":"2014","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2016.07.004_bib33","doi-asserted-by":"crossref","unstructured":"Choe H, van Besien K. Fludarabine, melphalan, 4Gy TBI conditioning for high-risk haplo-cord transplantation is well tolerated and results in prompt engraftment. Biol Blood Marrow Transplant 2016;22:S309-S310.","DOI":"10.1016\/j.bbmt.2015.11.778"},{"key":"10.1053\/j.seminhematol.2016.07.004_bib34","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.bbmt.2014.01.009","article-title":"Treosulfan, fludarabine, and 2-Gy total body irradiation followed by allogeneic hematopoietic cell transplantation in patients with myelodysplastic syndrome and acute myeloid leukemia","volume":"20","author":"Gyurkocza","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"issue":"28","key":"10.1053\/j.seminhematol.2016.07.004_bib35","doi-asserted-by":"crossref","first-page":"3152","DOI":"10.1200\/JCO.2014.60.4777","article-title":"Outcomes of nonmyeloablative HLA-haploidentical blood or marrow transplantation with high-dose post-transplantation cyclophosphamide in older adults","volume":"33","author":"Kasamon","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminhematol.2016.07.004_bib36","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1182\/blood-2015-04-639831","article-title":"Haploidentical transplant with posttransplant cyclophosphamide vs matched unrelated donor transplant for acute myeloid leukemia","volume":"126","author":"Ciurea","year":"2015","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2016.07.004_bib37","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/leu.2015.232","article-title":"Is there a stronger graft-versus-leukemia effect using HLA-haploidentical donors compared with HLA-identical siblings?","volume":"30","author":"Ringden","year":"2016","journal-title":"Leukemia"},{"key":"10.1053\/j.seminhematol.2016.07.004_bib38","doi-asserted-by":"crossref","unstructured":"van Besien K, Liu HT, Gergis U, et al. Haplo-cord UCB SCT with low cell dose, well matched UCB units. A prospective multicenter study. Blood 2014;124 (Suppl 1); abstr 1093.","DOI":"10.1182\/blood.V124.21.1093.1093"}],"container-title":["Seminars in Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S003719631630066X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S003719631630066X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T06:24:51Z","timestamp":1758522291000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S003719631630066X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":38,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["S003719631630066X"],"URL":"https:\/\/doi.org\/10.1053\/j.seminhematol.2016.07.004","relation":{},"ISSN":["0037-1963"],"issn-type":[{"value":"0037-1963","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Haploidentical cord transplantation\u2014The best of both worlds","name":"articletitle","label":"Article Title"},{"value":"Seminars in Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.seminhematol.2016.07.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}